Gut microbiome in biliary atresia

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Microbiome Research
• Immunology

Background:

• Biliary atresia (BA) is a progressive infant liver disease and the primary indication for pediatric liver transplantation.
• Current surgical treatments like Kasai portoenterostomy offer limited long-term success, often leading to cirrhosis.
• The gut microbiota plays a vital role in immune development and liver health, and is increasingly implicated in BA.

Purpose of the Study:

• To review and synthesize current literature on gut microbiota composition in biliary atresia.
• To explore the relationship between microbial profiles and clinical outcomes in BA patients.
• To identify potential mechanisms linking gut microbiota to BA pathogenesis and progression.

Main Methods:

• Systematic review of existing studies on gut microbiota in biliary atresia.
• Analysis of microbial composition before and after Kasai portoenterostomy.
• Correlation of microbial data with clinical outcomes and potential pathomechanisms.

Main Results:

• Consistent patterns of gut dysbiosis observed in BA patients, including an increase in pathobionts.
• Depletion of beneficial microbes, such as Bifidobacterium, is a common finding in BA.
• Microbial profiles are associated with clinical outcomes, suggesting roles in bile acid metabolism, translocation, and immune responses.

Conclusions:

• Gut microbiota dysbiosis is a significant factor in biliary atresia pathogenesis and progression.
• Understanding gut-liver-microbiota interactions is crucial for developing novel therapies.
• Targeting the gut microbiome may offer a promising strategy to improve native liver survival in BA.